37
Participants
Start Date
December 31, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting
Eligible opioid-dependent HIV-infected patients are randomly assigned to receive buprenorphine opioid agonist treatment for 12 months either in an integrated HIV primary care setting (intervention group) versus a non-integrated substance use treatment clinic setting (comparison group).
UCSF Positive Health Program, San Francisco
San Francisco Department of Public Health
OTHER_GOV
The New York Academy of Medicine
OTHER
Health Resources and Services Administration (HRSA)
FED
University of California, San Francisco
OTHER